Bell Investment Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.98K	Buy	159 +102	+179%	+$5.95K	﹤0.01%	718
2025 Q4	$3.39K	Buy	57 +15	+36%	+$817	﹤0.01%	1145
2025 Q3	$2.27K	Buy	42 +35	+500%	+$2K	﹤0.01%	1291
2025 Q2	$385	Sell	7 -31	-82%	-$1.82K	﹤0.01%	1811
2025 Q1	$2.69K	Buy	38 +15	+65%	+$1.01K	﹤0.01%	1188
2024 Q4	$1.51K	Buy	23 +10	+77%	+$670	﹤0.01%	1434
2024 Q3	$914	Sell	13 -19	-59%	-$1.59K	﹤0.01%	1621
2024 Q2	$2.63K	Buy	32 +5	+19%	+$416	﹤0.01%	1243
2024 Q1	$2.36K	Buy	27 +6	+29%	+$537	﹤0.01%	1282
2023 Q4	$2.02K	Sell	21 -16	-43%	-$1.42K	﹤0.01%	1318
2023 Q3	$3.27K	Buy	37 +16	+76%	+$1.42K	﹤0.01%	1030
2023 Q2	$1.82K	Buy	21 +6	+40%	+$565	﹤0.01%	1346
2023 Q1	$1.46K	Sell	15 -15	-50%	-$1.55K	﹤0.01%	1410
2022 Q4	$3.1K	Sell	30 -3	-9%	-$282	﹤0.01%	1051
2022 Q3	$3K	Hold	33	–	–	﹤0.01%	880
2022 Q2	$3K	Buy	+33	New	+$2.63K	﹤0.01%	899
2021 Q4	$4K	Buy	40 +2	+5%	+$165	﹤0.01%	835
2021 Q3	$3K	Buy	+38	New	+$3K	﹤0.01%	884